🔬February New Releases
🚀1,000+ new molecules for #Oncology, #Neurology, #Immunology, #Cardiovascular studies.
Key targets: #Hsp70, #MDM2, #EGFR/HER2, #M4, #Keap1-Nrf2, #IP6K. Includes first-in-class & clinical-stage compounds to boost #DrugDiscovery & #TargetValidation.